Virulent Strains of Helicobacter pylori Demonstrate Delayed Phagocytosis and Stimulate Homotypic Phagosome Fusion in Macrophages by Allen, Lee-Ann H. et al.
 
115
 
J. Exp. Med. 
 
Ó
 
 The Rockefeller University Press • 0022-1007/2000/01/115/13 $5.00
Volume 191, Number 1, January 3, 2000 115–127
http://www.jem.org
 
Virulent Strains of 
 
Helicobacter pylori
 
 Demonstrate Delayed 
Phagocytosis and Stimulate Homotypic Phagosome Fusion 
in Macrophages
 
By Lee-Ann H. Allen,
 
*
 
‡
 
 Larry S. Schlesinger,
 
*
 
 and Byoung Kang
 
*
 
From the 
 
*
 
Department of Medicine and the 
 
‡
 
Inﬂammation Program, University of Iowa and 
Veterans Affairs Medical Center, Iowa City, Iowa 52242
 
Abstract
 
Helicobacter pylori
 
 colonizes the gastric epithelium of 
 
z
 
50% of the world’s population and plays
a causative role in the development of gastric and duodenal ulcers. 
 
H
 
.
 
 pylori
 
 is phagocytosed by
mononuclear phagocytes, but the internalized bacteria are not killed and the reasons for this
host defense defect are unclear. We now show using immunofluorescence and electron mi-
croscopy that 
 
H
 
.
 
 pylori
 
 employs an unusual mechanism to avoid phagocytic killing: delayed en-
try followed by homotypic phagosome fusion. Unopsonized type I 
 
H
 
.
 
 pylori
 
 bound readily to
macrophages and were internalized into actin-rich phagosomes after a lag of 
 
z
 
4 min. Although
early (10 min) phagosomes contained single bacilli, 
 
H
 
.
 
 pylori
 
 phagosomes coalesced over the
next 
 
z
 
2 h. The resulting “megasomes” contained multiple viable organisms and were stable for
24 h. Phagosome–phagosome fusion required bacterial protein synthesis and intact host micro-
tubules, and both chloramphenicol and nocodazole increased killing of intracellular 
 
H
 
.
 
 pylori
 
.
Type II strains of 
 
H
 
.
 
 pylori
 
 are less virulent and lack the 
 
cag
 
 pathogenicity island. In contrast to
type I strains, type II 
 
H
 
.
 
 pylori
 
 were rapidly ingested and killed by macrophages and did not
stimulate megasome formation. Collectively, our data suggest that megasome formation is an
important feature of 
 
H
 
.
 
 pylori
 
 pathogenesis.
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Introduction
 
Helicobacter pylori
 
 (Hp)
 
1
 
 is a microaerophilic gram-negative
bacterium that colonizes the gastric epithelium of at least
50% of the world’s population and plays a causative role in
the development of chronic gastritis, gastric and duodenal
ulcers, and gastric adenocarcinoma (1, 2). One hallmark of
Hp is its persistence in spite of the host immune response,
and colonization of the stomach is associated with bacterial
replication followed by chronic inflammation. The im-
mune response to Hp is characterized by the production of
IgG and secretory IgA, the synthesis and release of pro-
inflammatory cytokines such as IL-6, IL-8, GM-CSF, and
TNF-
 
a
 
, and the recruitment of neutrophils, mononuclear
phagocytes, and lymphocytes to the gastric mucosa (1–4).
Phagocyte recruitment correlates directly with the ability of
bacteria to induce gastritis, and it is thought that both bac-
terial products and host inflammatory mediators contribute
to the subsequent tissue damage (1–3). To date, strains of
Hp have been divided into two groups (4–7). Type I strains
contain the 
 
cag
 
 pathogenicity island (PAI) and secrete a vac-
uolating cytotoxin (VacA). In contrast, type II strains lack
the 
 
cag
 
 PAI and synthesize small amounts of inactive VacA.
Type I strains are more prevalent in persons with ulcer dis-
ease and induce more inflammation and tissue damage than
do the less virulent type II strains (1–3, 8).
The available data suggest that bacterial persistence can
be explained in part by the failure of Hp to be killed by
professional phagocytes. Phagocytosis occurs in vivo, par-
ticularly at sites of tissue damage such as ulcer margins and
in regions of metaplasia (9–12). Unopsonized Hp bind
readily to mononuclear phagocytes and neutrophils, and
organisms are internalized into close-fitting phagosomes
(13–17). Importantly, however, only about half of the in-
gested bacilli are killed (16–18). The reasons for this host
defense defect are unknown, and Hp–phagocyte interac-
tions are only beginning to be explored at the molecular
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level. As phagocytosis is an essential component of the in-
nate immune response, it is likely that the failure of mac-
rophages and neutrophils to eliminate ingested Hp contrib-
utes significantly to bacterial persistence.
Many pathogenic microorganisms evade killing in mac-
rophages by preventing phagosome–lysosome fusion. For
example, 
 
Listeria monocytogenes
 
 and 
 
Shigella flexneri
 
 escape
from the phagosome and replicate in the cytosol (for review
see reference 19). 
 
Legionella pneumophilia
 
 resides in a compart-
ment that does not fuse with endosomes or lysosomes (19),
and phagosomes containing pathogenic mycobacteria fuse
with endosomes but do not acidify (19–21). In contrast,
pathogens such as 
 
Coxiella
 
 survive and replicate in acidic
phagolysosomes (19). Thus far, the Hp phagosome has not
been characterized. To this end, we used immunofluores-
cence and electron microscopy (EM) to monitor ingestion
of Hp by human and murine macrophages. We now show
that phagocytosis of virulent type I Hp (but not less viru-
lent type II organisms) exhibits two unusual features. First,
actin polymerization and phagosome formation are delayed
until several minutes after bacterial attachment to macro-
phages. Second, Hp phagosomes undergo extensive clus-
tering and fusion during the first few hours after bacterial in-
gestion. Organisms inside these “megasomes” remained viable
for at least 24 h. Collectively, our data support the hypothesis
that intracellular Hp reside in a protected niche (16, 22).
 
Materials and Methods
 
Materials.
 
Trypticase soy agar, Brain heart infusion broth,
Luria-Bertani broth (LB), and LB agar were obtained from Difco
Labs., Inc. Pyrogen-free tissue culture reagents Dulbecco’s (D)PBS,
RPMI, Hepes–RPMI, MEM
 
a
 
, DMEM, 
 
l
 
-glutamine, and peni-
cillin/streptomycin were from BioWhittaker, Inc. FBS was from
HyClone or GIBCO BRL. Round glass coverslips (12 mm) were
from Fisher Scientific Co. PMA was from LC Labs. Live-Dead
 
Bac
 
Light Bacterial Viability Kit, rhodamine–phalloidin, FITC–
phalloidin, acridine orange, and 4
 
9
 
,6-diamidino-2-phenylindole
hydrochloride (DAPI) were from Molecular Probes, Inc. Poly-
clonal (p)Abs to Hp (YVS-6601) were from Accurate Chemical
and Science Corp. Mouse mAbs to 
 
b
 
-tubulin (1111876) were ob-
tained from Boehringer Mannheim. Affinity-purified tetramethyl-
rhodamine isothiocyanate (TRITC)- or FITC-conjugated donkey
anti–rabbit IgG F(ab
 
9
 
)
 
2
 
 and FITC-conjugated goat anti–mouse
IgG
 
1
 
IgM were from Jackson ImmunoResearch Labs., Inc. Mouse
mAbs to talin (8d4) and other reagents were obtained from Sigma
Chemical Co.
 
Bacterial Strains and Culture Conditions.
 
Type I (11637 [type strain]
and 60190) and type II (Tx30a) Hp were obtained from the Amer-
ican Type Culture Collection (ATCC). Hp were grown on trypti-
case soy agar, pH 6, containing 5% sheep blood (Remel) under
microaerophilic conditions (5% O
 
2
 
, 10% CO
 
2
 
, 85% N
 
2
 
) and 98%
humidity in a Heraeus trigas incubator (Heraeus Instruments) at
37
 
8
 
C. Fresh plates were started from glycerol stocks each week
and passaged after 48 h. Where indicated, liquid cultures of Hp
were grown in Brain heart infusion broth containing 10% heat-
inactivated (HI) FBS. Avirulent plasmid-cured 
 
Yersinia enterocolit-
ica
 
 (Ye) 8081c (23) was grown overnight in LB or on LB agar at
30
 
8
 
C. Bacteria from plates or liquid cultures were washed with
DPBS, and concentrations were estimated using OD
 
600
 
 
 
5 
 
0.1 as
 
10
 
8
 
 Hp or 5 
 
3
 
 10
 
7
 
 Ye. Viability of washed bacteria was deter-
mined by vital staining using the Live-Dead 
 
Bac
 
Light Bacterial
Viability kit according to the manufacturer’s instructions. Cultures
with 
 
,
 
90% viable organisms were discarded. For experiments us-
ing dead organisms, Hp were killed by heating to 65
 
8
 
C for 10 min.
 
Macrophage Isolation and Culture.
 
Resident macrophages were
harvested by peritoneal lavage from female CD-1 (ICR) mice
(Charles River Labs.; references 24 and 25) and plated in MEM
 
a
 
supplemented with 10% HI FBS, 1% 
 
l
 
-glutamine, 100 U/ml pen-
icillin G, and 100 
 
m
 
g/ml streptomycin. After 2 h at 37
 
8
 
C, lympho-
cytes were removed by washing, and adherent macrophages were
incubated overnight at 37
 
8
 
C in antibiotic-free medium before
use. The murine macrophage cell line J774a.1 (ATCC TIB-67)
and U-937 human histiocytic lymphoma cells (ATCC CRL-
1593.2) were grown in DMEM or RPMI supplemented with HI
FBS, 
 
l
 
-glutamine, penicillin, and streptomycin as indicated above.
U-937 cells were differentiated into adherent macrophage-like
cells in medium containing 20 nM PMA for 48–72 h (26) before
use. Human monocyte-derived macrophages (MDMs) were ob-
tained by culturing PBMCs in teflon wells for 5 d at 37
 
8
 
C in
RPMI containing 10% HI autologous serum (27) and were a gift
from Dr. Richard Fawcett (University of Iowa). MDMs were
purified by adherence to collagen-coated coverslips. All macro-
phages were incubated for at least 16 h in antibiotic-free medium
before contact with bacteria.
 
Synchronized Phagocytosis and Phagocytic Killing.
 
Bacteria were
dispersed in Hepes–RPMI containing 10% HI FBS at a ratio of
25 bacteria/macrophage unless indicated otherwise, and phago-
cytosis was synchronized by centrifugation. Hp and Ye were bound
to macrophages by a 3-min, 12
 
8
 
C spin at 600 
 
g
 
, and phagocytosis
was initiated by rapid warming to 37
 
8
 
C after a DPBS wash. At-
tachment indices (bacteria per 100 macrophages), phagocytic in-
dices (phagosomes per 100 macrophages), and bacterial viability
after 0–60 min at 37
 
8
 
C was determined using vital staining. Mac-
rophages were washed three times with DPBS (to remove any
unbound organisms), permeabilized with 1 mg/ml saponin (5
min, 25
 
8
 
C), and stained with 
 
Bac
 
Light reagents diluted in DPBS.
Green (viable) and red (dead) cell-associated bacteria were counted
using fluorescence microscopy. At least 300 consecutive macro-
phages were counted per experiment in triplicate samples. Paral-
lel staining of unpermeabilized macrophages determined that the
fraction of cell-associated bacteria that was not ingested was 
 
,
 
5%
at 30 min. Phagocytic killing at later time points (2–24 h) was de-
termined using the gentamicin-CFU method (28). In brief,
uningested organisms were killed by adding 100 
 
m
 
g/ml gentami-
cin (BioWhittaker, Inc.) to the culture medium 1 h after initiation
of phagocytosis. After 60 min in gentamicin, macrophages were
washed and returned to antibiotic-free medium at 37
 
8
 
C. 2–24 h
after initiation of phagocytosis, diluted macrophage lysates were
plated in triplicate for determination of CFU.
 
Immunofluorescence Microscopy.
 
For immunofluorescence micros-
copy (IFM), cells were plated on uncoated acid-washed glass cover-
slips in 35-mm dishes (peritoneal macrophages, J774, or PMA-
treated U-937) or coverslips coated with collagen (MDMs) to
achieve 1–2 
 
3
 
 10
 
5
 
 cells per 12-mm coverslip. After the desired
treatments, macrophages were fixed in 10% buffered formalin
(Sigma Chemical Co.) and permeabilized in 
 
2
 
20
 
8
 
C acetone (24,
25). Fixed cells were blocked overnight at 4
 
8
 
C in DPBS contain-
ing 0.5 mg/ml NaN
 
3
 
, 5 mg/ml BSA, and 10% horse serum
(blocking buffer) and then incubated sequentially with primary
and secondary Abs or fluorescent phalloidins, washed, and mounted
using mowiol as we previously described (24, 25). Staining with
phalloidins detects F-actin on forming phagosomes and correlates 
117
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with particle ingestion (24, 25). Reagents were diluted in block-
ing buffer as follows: anti-Hp pAb, 1:3,000; FITC–phalloidin, 1:300;
rhodamine–phalloidin, 1:500; anti–
 
b
 
-tubulin mAb, 1:50; antitalin
mAb, 1:200; and all secondary Abs, 1:100 or 1:200. Specificity of
staining was verified by omission of primary Abs and by the use
of mouse, rabbit, or rat isotype control Abs (Zymed Labs., Inc.).
Immunofluorescence was viewed using a Zeiss Axioplan2 photo-
microscope (Carl Zeiss, Inc.). Cells were photographed using
Kodak Ektachrome ASA 400 color slide film (Eastman Kodak Co.).
Composite images were generated using Adobe Photoshop 3.0
(Adobe Systems, Inc.).
 
Transmission Electron Microscopy.
 
Macrophages (8 
 
3 
 
10
 
5
 
 per
glass coverslip) were incubated with Hp at a ratio of 100 bacteria/
cell, and phagocytosis was synchronized using centrifugation as
described above. Gentamicin treatment was performed as de-
scribed above except that the drug was added 2 h after initiation of
phagocytosis. After 10 min–24 h at 37
 
8
 
C, infected macrophages
were fixed in 2.5% glutaraldehyde/0.1 M sodium cacodylate
buffer, and samples were processed for transmission (T)EM essen-
tially as previously described (29, 30). Samples were examined using
a Hitachi H-7000 transmission electron microscope in the Univer-
sity of Iowa Central Microscopy Research Facility. To quantify
phagosome–phagosome fusion, the number of bacilli in each mac-
rophage section and the number of bacilli per phagosome were
counted in samples from one to three independent experiments.
For each sample containing strain 11637, at least 50 sections and
200 phagosomes were scored. For strain Tx30a, a minimum of 46
sections and 100 phagosomes was scored.
 
Quantitation of Coalesced Phagosomes Using Fluorescence Microscopy.
 
Macrophages were infected with bacteria and processed for IFM
as indicated above. Fixed and permeabilized cells on triplicate
coverslips were stained with DAPI (1:1,000 dilution) to detect
Ye or with anti-Hp pAbs and FITC- or TRITC-conjugated sec-
ondary Abs. The number of phagosomes in 
 
$
 
200 macrophages
per coverslip was counted using fluorescence and phase optics.
Phagosomes with apparent diameters greater than three bacilli
were scored as megasomes, and all others were scored as single
phagosomes. For each experiment, cell-associated bacterial aggre-
gates (originating from bacterial stock suspensions) were enumer-
ated in samples fixed immediately after the centrifugation step or
after 5 min at 37
 
8
 
C, and these values were subtracted from the
data shown.
 
Other Methods. 
 
To depolymerize microtubules (MTs), mac-
rophages were pretreated with 2 
 
m
 
g/ml nocodazole or 2 
 
m
 
g/ml
colcemid for 10 min at 37
 
8
 
C before addition of Hp and initiation
of phagocytosis. Depolymerization was confirmed by staining no-
codazole- or colcemid-treated cells with mAbs to 
 
b
 
-tubulin (31).
After 20 h in medium containing nocodazole or colcemid, 10–15%
of the macrophages had detached from the culture surface. There-
fore, for overnight time points, both adherent cells and macro-
phages in the culture medium were collected for determination of
CFU. To inhibit protein synthesis, macrophages or Hp were pre-
incubated for 30 min at 37
 
8
 
C in Hepes–RPMI containing 100 
 
m
 
g/
ml cycloheximide or 30–100 
 
m
 
g/ml chloramphenicol, and inhib-
itors were maintained in the culture medium during and after
phagocytosis. Protein synthesis was quantified by labeling tripli-
cate cultures of 3 
 
3 
 
10
 
5
 
 macrophages or 6 
 
3 
 
10
 
8
 
 Hp with 15 
 
m
 
Ci/
ml [
 
35
 
S]methionine–cysteine Express Protein Labeling Mix (43.5
TBq/mmol; New England Nuclear) in methionine/cyteine-free
RPMI (GIBCO BRL) in the presence or absence of chloram-
phenicol and cycloheximide for 2 h at 37
 
8
 
C. Incorporation of ra-
dioactivity into proteins was quantified by precipitation with 10%
TCA and liquid scintillation counting (32). Protein concentra-
tions were determined using the BCA Protein Assay Kit (Pierce
Chemical Co.). Assessment of Hp uptake using the double-immu-
nofluorescence method was performed using anti-Hp pAbs essen-
tially as previously described (33).
 
Results
 
Type I Hp Are Ingested by Macrophages yet Resist Phagocytic
Killing. Previous studies have shown that unopsonized
Hp is inefficiently killed by human phagocytes (16–18). Sim-
ilarly, we found that Hp 11637 or 60190 remained viable
in resting mouse peritoneal macrophages or J774 cells 24 h
after ingestion, whereas avirulent Ye 8081c did not (Fig. 1).
The ability of pathogens such as Mycobacterium tuberculosis
(19, 21) to disrupt phagosome maturation and phagosome–
lysosome fusion is thought to be an important aspect of
bacterial virulence and survival. However, the mechanism
by which type I strains of Hp resist phagocytic killing is
unknown. In this study, we used IFM and TEM to charac-
terize the Hp phagosome.
Phagosome morphology and the kinetics of bacterial in-
gestion were followed using FITC– or rhodamine–phalloi-
din and fluorescence microscopy (Fig. 2). As neither Ye nor
Hp bound to macrophages at 48C, phagocytosis was syn-
chronized using centrifugation. Ye, which binds to b1 inte-
grins (34), was rapidly internalized into close-fitting conven-
tional phagosomes (Fig. 2). The kinetics of Ye uptake were
similar to those we obtained previously for zymosan, IgG
beads, and complement-opsonized particles (24, 25). Hp
11637 and 60190 were also detected in close-fitting phago-
somes. However, unlike with Ye or other particles, both
actin rearrangements beneath attached Hp and phagosome
formation were significantly delayed relative to bacterial
Figure 1. Phagocytic killing of Hp by murine macrophages is im-
paired. Peritoneal macrophages were incubated with Hp 11637 or Ye
8081c at a ratio of 1:25, and phagocytosis was synchronized using centrif-
ugation. As indicated in Materials and Methods, bacterial viability before
gentamicin treatment (15 min and 1 h) was determined by vital staining
of permeabilized macrophages, whereas viability at later times (2–24 h)
was determined by plating macrophage lysates for CFU. Data shown are
the average 6 SD of three independent experiments. Note that the y-axis
is a log scale. Comparable data were obtained using Hp 60190 and J774
cells (not shown). Similar killing curves were generated using 5–100 bac-
teria per phagocyte (not shown). Mf, macrophage.118 Phagocytosis of Helicobacter pylori
binding (Fig. 2). Thus, most Ye were phagocytosed within
0.5–1 min, whereas actin polymerization in the vicinity of
bound Hp was negligible until 3–4 min and peaked at 5–7
min. Ingestion kinetics similar to those shown in Fig. 2 (i.e.,
a delay with virulent Hp) were also obtained using Abs to
the cytoskeletal protein talin or using the double-immu-
nofluorescence method (data not shown). Moreover, in con-
trast to viable organisms, ingestion of dead Hp resembled
Ye and occurred without a lag; 81.3 6 7.0% of cell-associ-
ated heat-killed Hp were in actin-positive phagosomes after
1 min at 378C (n 5 3). Neither the receptor that mediates
phagocytosis of Hp nor the accompanying signaling events
have been elucidated. Nevertheless, it is tempting to specu-
late that delayed uptake of Hp may reflect alterations of the
internalization process that are important for bacterial sur-
vival in macrophages.
Hp Phagosomes Rapidly Coalesce into Structures Containing
Multiple Organisms. Further characterization of the Hp
phagosome demonstrated that phagosomes containing virulent
Hp underwent extensive clustering followed by homotypic
fusion. In initial experiments using light microscopy (LM),
we found that shortly after bacterial uptake Hp, phagosomes
appeared to cluster in the cytoplasm as if they were actively
migrating toward one another (Fig. 3 A). Over the next z2 h,
phagosome clustering continued and was followed by the
appearance of larger phagosomes containing multiple viable
organisms (Fig. 3, A and B). These structures were stable for
at least 24 h (Fig. 3 A). Due to their unusual morphology,
we have named these large Hp phagosomes “megasomes.”
As judged by IFM, we found that megasomes formed simi-
larly in peritoneal macrophages, MDMs, J774 cells (Fig.
3 B), and PMA-treated U-937 cells (data not shown). Af-
ter 2 h at 378C, the percentage of infected macrophages con-
taining at least one megasome was 65.5 6 10.4 (n 5 4). Due
to the z6 h doubling time of Hp, it is unlikely that bacte-
rial replication contributed to initial megasome formation.
However, we cannot exclude a role for Hp replication in
megasome maintenance (i.e., at times .6 h). The shape of
the killing curve shown in Fig. 1 indicates that Hp remains
viable yet may not replicate inside macrophages. Impor-
tantly, it is unlikely that megasomes contained Hp aggre-
gates. In contrast to organisms such as M. tuberculosis, viable
Hp are not prone to aggregation (Allen, L., unpublished ob-
servation). Moreover, the frequency of cell-associated aggre-
gates was quantified for each experiment and did not exceed
2.1% for Hp or 3.2% for Ye.
Figure 2. Ingestion of Hp by macrophages is delayed relative to bacte-
rial binding. Phagocytosis of Hp 11637 or Ye by peritoneal macrophages
was synchronized using centrifugation. After incubation at 378C for the
indicated times, forming phagosomes were detected by staining fixed and
permeabilized macrophages with FITC– or rhodamine–phalloidin, and
cell-associated organisms were detected using phase contrast microscopy.
(A) Representative forming phagosomes containing Hp or Ye. Left col-
umn, phase contrast; Right column, F-actin. Forming phagosomes con-
taining Ye were abundant after 0.5 min at 378C (arrows, bottom panels).
Actin rearrangements were not detected beneath bound Hp after 2 min at
378C (arrows, top panels); however, numerous Hp phagosomes were de-
tected after 4 min at 378C (arrows, center panels). (B) Kinetics of phago-
some formation and bacterial ingestion. Adherent macrophages ingested
Hp or Ye for 0–15 min at 378C before processing for IFM. F-actin was
detected as in A, and the results are expressed as the percentage of actin-
positive cell-associated bacteria over time. The total number of cell-asso-
ciated bacteria per 100 macrophages did not change significantly over the
time course of the experiment: 800 6 87 Hp and 771 6 106 Ye at 1 min,
and 882 6 91 Hp and 800 6 92 Ye at 15 min. Data shown are the aver-
age 6 SD from three independent experiments conducted in triplicate. At
least 300 bacteria were scored per sample per time. Comparable data were
obtained using J774 cells or Hp 60190 (not shown).119 Allen et al.
We next used TEM to assess the structure of Hp mega-
somes at higher resolution. Ultrastructural analysis confirmed
that Hp was phagocytosed in a conventional manner and
that 93% of early (10 min) phagosomes contained single or-
ganisms (Table I and Fig. 4, A and B). The remaining 10
min phagosomes appeared to contain two to three organisms
each (Fig. 5). Importantly, our EM data confirmed that me-
gasomes were large phagosomes containing multiple intact
Hp (Fig. 4, C–F). Moreover, the results of quantitation ex-
periments demonstrated that megasomes increased in both
size and number over time (Figs. 4 and 5 and Table I), con-
sistent with the hypothesis that phagosome–phagosome fu-
sion was progressive. After 30 min, the average megasome
contained two to three Hp (range, 2–9), and by 24 h the
average megasome contained z10 Hp (range, 2–50). The
extent of phagosome–phagosome fusion is illustrated by
the fact that 87–90% of Hp were inside megasomes after 24 h
(Table I). Although the vast majority of Hp were inside
megasomes after 6–24 h, we did detect many phagosomes
containing single Hp in these samples (Table I). Importantly,
however, these single phagosomes were usually in close
proximity to a megasome (Fig. 4, D and E). Therefore,
some or all of these “single” phagosomes may have been
connected to the adjacent megasome in a plane of the
macrophage that was not examined. Similar data were ob-
tained for peritoneal macrophages and J774 cells (Table I)
and are in good agreement with the results of our LM ex-
periments (Fig. 3 B). That more megasomes were detected
by TEM than IFM likely reflects both the limited resolu-
tion of the light microscope and the fact that only very
Figure 3. Hp phagosomes rapidly coalesce inside macrophages. Phagocytosis of
Hp by adherent macrophages was synchronized as described above. After 1–20 h
at 378C, samples were processed for IFM. (A) Top panels, appearance of Hp mega-
somes 1–20 h after initiation of phagocytosis of Hp 60190. Peritoneal macro-
phages, 1–2 h panels; J774 cells, 20 h panels. Fixed and permeabilized cells were
stained with pAbs to Hp and secondary Abs conjugated to FITC or TRITC. Left
panels, phase contrast; right panels, Hp phagosomes. Arrowheads, small/conven-
tional phagosomes; arrows, Hp megasomes. Note that 2 h megasomes are larger
than 1 h megasomes. Bottom panels: 6 h after ingestion of Hp 11637, live mac-
rophages were permeabilized with saponin and stained with BacLight reagents.
Hp emitted green fluorescence, demonstrating that these bacteria were viable in-
side megasomes (right panel, greyscale image of emitted green fluorescence; left
panel, phase contrast). Arrows, Hp; N, macrophage nucleus. (B) Time course of
megasome formation. Peritoneal macrophages (PM) or human MDMs ingested
Hp 11637 or 60190 for the indicated times. Fixed-permeabilized cells were
stained with Abs to Hp as described above. Phagosomes were scored as small/
conventional or large/megasomes as described in Materials and Methods. The
graph indicates the number of megasomes as a percentage of total Hp phago-
somes. Data shown are the average 6 SD of three independent experiments con-
ducted in triplicate (PMs) or duplicate (MDMs). nd, not determined.120 Phagocytosis of Helicobacter pylori
large phagosomes were scored as megasomes for the data
shown in Fig. 3 B. Taken together, our data suggest that
Hp utilizes an unusual mechanism to avoid phagocytic kill-
ing that involves both delayed entry and homotypic phago-
some fusion.
Megasome Formation Requires Bacterial Protein Synthesis and
Intact MTs. Intracellular organelle transport is mediated
by the cytoskeleton, and previous studies have shown that
phagosomes move bidirectionally along microtubular tracts
in macrophages (35, 36). As clustering and fusion of Hp
phagosomes appeared to be highly dynamic, we explored
the role of MTs in this process. MTs were not essential for
Hp phagocytosis, and the rate of Hp ingestion was not al-
tered in nocodazole-treated cells (Fig. 6). In contrast, we
found that depolymerization of macrophage MTs with ei-
ther nocodazole or colcemid inhibited megasome forma-
tion by z90% (Fig. 7 A), and the few megasomes that did
form were reduced in size (compare Fig. 7 B to Fig. 5, 2 h
time point). Moreover, in the absence of intact MTs, 99%
of ingested Hp were killed (Fig. 7 C). However, neither drug
impaired Hp viability in the absence of macrophages (data
not shown). Efficient phagocytic killing of Hp in the ab-
sence of MTs was somewhat surprising, as MT-destabilizing
drugs can reduce killing of some microorganisms via their
ability to block phagosome–lysosome fusion (37). Never-
theless, we found that Ye was also killed by nocodazole-
treated macrophages (2 logs killing at 3 h in the presence of
nocodazole vs. 1.5 logs killing in the absence of the drug,
n 5 3). These data suggest that nonlysosomal killing mech-
anisms were bacteriocidal under these conditions. Although
the exact nature of the Hp phagosome remains undefined,
our data indicate that megasome formation is important for
Hp survival in macrophages.
We next examined whether eukaryotic or bacterial pro-
Table I. Quantitation of Phagosome Size
Time Sections Size*
Percent of total
phagosomes
Percent of
total Hp
P.Mf
10 min 54 single 93.1 85.0
mega. 6.9 15.0
30 min 60 single 70.7 45.9
mega. 29.3 54.1
2 h 58 single 76.9 45.8
mega. 23.1 54.2
24 h 52 single 43.9 9.4
mega. 56.1 90.6
J774
30 min 56 single 68.0 34.5
mega. 32.0 65.5
2 h 57 single 75.9 41.1
mega. 24.1 58.9
6 h 53 single 69.0 24.2
mega. 31.0 75.8
24 h 54 single 51.6 12.6
mega. 48.4 87.4
Peritoneal macrophages or J774 cells ingested H. pylori 11637 for the
indicated times, and for each condition at least 200 phagosomes were
scored. Data shown are the number of single phagosomes (single) and
megasomes (mega.) as a percentage of total phagosomes, and the distri-
bution of Hp between the two types of phagosomes (total Hp).
P.Mf, peritoneal macrophage.
*Single phagosomes contain one bacterium; mega. phagosomes contain
two or more organisms.
Figure 4. Ultrastructure of Hp phagosomes in macrophages. Peritoneal
macrophages (A–D, G, H) or J774 cells (E and F) were infected with Hp
11637 (A–F) or Tx30a (G and H) at a ratio of 100 bacteria/macrophage.
At various times after bacterial ingestion, samples were processed for
TEM as described in Materials and Methods. (A) Ingestion of Hp. (B) 10
min phagosomes containing single bacteria. (C) 30 min megasome. (D
and F) 24 h megasomes. (E) 6 h megasome in a J774 cell. Arrows in D
and E indicate single phagosomes adjacent to megasomes. (G and H) 30
min phagosomes containing Tx30a. These type II Hp were found in con-
ventional phagosomes (H, arrows), and some of the organisms appeared
degraded (G, arrows). Arrowhead in G indicates a rare Tx30a phagosome
that might contain two organisms. Magnifications: A and C, 20,000; B,
10,000; D, E, G, and H, 7,000; F, 12,000.121 Allen et al.
tein synthesis played a role in megasome formation. Hp and
macrophages were pretreated with chloramphenicol or cy-
cloheximide for 30 min at 378C before initiation of phago-
cytosis, and inhibitors remained in the culture medium for the
duration of each experiment. As shown in Fig. 7 A, we
found that the bacterial protein synthesis inhibitor chloram-
phenicol reduced phagosome–phagosome fusion in a dose-
dependent manner: megasome formation was reduced 16
and z72% by 30 and 100 mg/ml chloramphenicol, respec-
tively. On the other hand, megasome formation did not
change significantly in the presence of the eukaryotic pro-
tein synthesis inhibitor cycloheximide (Fig. 7 A). These data
suggest that clustering and fusion of Hp phagosomes was
induced by metabolically active Hp yet was independent of
macrophage protein synthesis. Consistent with this hypoth-
esis, we found that heat-killed Hp did not induce mega-
some formation, and 98.1 6 1.2% of these bacteria were in-
side single phagosomes (n 5 5). [35S]methionine labeling
experiments demonstrated the efficacy and specificity of
the inhibitors used: 100 mg/ml of cycloheximide inhibited
macrophage protein synthesis 79.8 6 7.7% and Hp protein
synthesis 1.0 6 4.9%; 30 mg/ml of chloramphenicol inhib-
ited macrophage protein synthesis 19.6 6 18.0% and Hp
protein synthesis 46.2 6 15.0%; and 100 mg/ml of chloram-
phenicol inhibited macrophage protein synthesis 19.5 6 1.1%
and Hp protein synthesis 69.8 6 6.7% (n 5 3).
Next, we determined if bacterial protein synthesis was
required for Hp uptake or intracellular killing. In addition
to its effects on protein synthesis, chloramphenicol is bacterio-
static for most microorganisms (38, 39). We found that the
OD600 of Hp liquid cultures declined by 13 6 4% (n 5 3)
after 20 h in medium containing 100 mg/ml of chloram-
phenicol, whereas the optical density of control cultures in-
creased threefold. Although chloramphenicol was not toxic
to Hp in the absence of macrophages, this drug dramati-
cally increased phagocytic killing such that only z1% of in-
gested organisms survived (Fig. 7 B). In contrast to the
MT-destabilizing agents discussed above, chloramphenicol
also affected the rate of Hp entry (Fig. 6), and maximum
Figure 5. Megasomes increase in size and number over time. Perito-
neal macrophages (top panel) or J774 cells (bottom panel) ingested Hp
11637 for the indicated times before processing for TEM. To assess
whether phagosome–phagosome fusion was progressive, both the total
number of megasomes (Table I) and the number of bacteria per megasome
(this figure) was scored in cell sections as described in Materials and Meth-
ods. “Frequency” indicates the number of megasomes containing 2 Hp
(black bars), 3–5 Hp (white bars), or .5 Hp (hatched bars) at each time
point. Phagosomes containing single Hp are not shown in this figure.
Figure 6. Kinetics of phagocytosis of Hp 11637 and Tx30a. Top panel:
peritoneal macrophages were infected with Hp 11637 or Tx30a, and the
kinetics of phagocytosis were followed in fixed and permeabilized cells
double-stained with Abs to Hp and FITC–phalloidin. Results are ex-
pressed as described for Fig. 2 B. In contrast to the wild-type strain, phago-
cytosis of Tx30a was not significantly delayed relative to bacterial binding.
Data shown are the average 6 SD of three (11637) or five (Tx30a) inde-
pendent experiments conducted in triplicate. Bottom panel: effect of no-
codazole (Nocod.) and chloramphenicol (Chlor.) on the rate of phagocy-
tosis of Hp 11637. Phagocytosis assays were performed in the presence of
2 mg/ml nocodazole or 100 mg/ml chloramphenicol as described above.
Inhibition of bacterial protein synthesis, but not depolymerization of
MTs, increased the rate of phagocytosis of Hp 11637. Data shown are the
average 6 SD of two (nocodazole) or four (chloramphenicol) indepen-
dent experiments run in triplicate.122 Phagocytosis of Helicobacter pylori
phagocytosis occurred within 1–3 min of bacterial binding.
Collectively, these data indicate that only metabolically ac-
tive Hp exhibited delayed phagocytosis followed by mega-
some formation. The data support the hypothesis that Hp
modifies its environment in macrophages and indicate a role
for megasome formation in Hp persistence.
Type II Hp Are Rapidly Ingested and Killed by Macrophages
and Are Not Found in Megasomes. Type II strains of Hp lack
the cag PAI in the chromosome, produce a nontoxic form
of VacA, and are thought to be less virulent (1–3). How-
ever, the interaction of type II Hp with macrophages has
not been explored. Therefore, we determined if Hp Tx30a
(5) was more susceptible to phagocytic killing than were
11637 or 60190 and if these bacteria were found in mega-
somes. Using both LM and TEM, we found that unop-
sonized Tx30a readily bound to macrophages, and adher-
ent bacilli were internalized into conventional close-fitting
phagosomes (Fig. 4, G and H). Phagocytosis of Tx30a was
rapid, and actin-positive phagosomes were numerous after
1–3 min at 378C (Fig. 6). In this regard, uptake of Tx30a
resembled that of chloramphenicol-treated 11637 (Fig. 6).
In contrast to type I Hp, phagosomes containing Tx30a did
not coalesce (Fig. 4, G and H, and Fig. 8 A). As judged by
IFM, megasome formation was reduced by 75 and 72% 0.5
and 2 h after ingestion, respectively (Fig. 8 A). Similarly,
ultrastructural analysis of 102 phagosomes in sections from
46 macrophages demonstrated that 94% of Tx30a phago-
somes appeared to contain single bacilli (Fig. 4, G and H).
Three Tx30a phagosomes may have contained two organ-
isms each (Fig. 4 G, arrowhead). However, it was unclear
whether these three organelles contained pairs of bacilli or
whether there was a sectioning artifact. Larger vacuoles were
not observed. Significantly, we also found that Tx30a was
more susceptible to phagocytic killing than wild-type Hp.
Figure 7. Nocodazole and chloramphenicol inhibit megasome formation and increase intracellular killing of Hp. Peritoneal macrophages and Hp were
treated with 2 mg/ml nocodazole, 30–100 mg/ml chloramphenicol, or 100 mg/ml cycloheximide as described in Materials and Methods. Megasome for-
mation and megasome size was scored using LM and TEM. Phagocytic killing was assayed as described above. (A) Nocodazole and chloramphenicol in-
hibit megasome formation. Macrophages and Hp were treated with nocodazole (Nocod.), chloramphenicol (Clr.), or cycloheximide (Chx.) as indicated,
and samples were fixed-processed for LM and TEM 2 h after initiation of phagocytosis. The graphs show the number of megasomes as a percentage of all
Hp phagosomes. Top panel: megasomes were scored in fixed and permeabilized cells using LM. Data shown are the average 6 SD of three to six inde-
pendent experiments performed in triplicate. Bottom panel, effect of 100 mg/ml chloramphenicol and 2 mg/ml nocodazole on megasome formation as
judged by TEM. Con., control. (B) Effect of 2 mg/ml nocodazole and 100 mg/ml chloramphenicol on megasome size. Macrophages were fixed and pro-
cessed for TEM 2 h after initiation of phagocytosis. “Frequency” indicates the number of megasomes containing 2 Hp (black bars), 3–5 Hp (white bars),
or .5 Hp (hatched bars). The size of 2 h megasomes in control macrophages is shown in Fig. 5. (C) Macrophages and Hp 11637 were left untreated or
incubated with 2 mg/ml nocodazole or 100 mg/ml chloramphenicol, and phagocytic killing was measured after 0.5–20 h. Data shown are the average 6
SD of four independent experiments.123 Allen et al.
Damaged Tx30a were detected inside phagosomes as early
as 30 min after ingestion (Fig. 4 G, arrows), and by 20 h, 99%
of ingested organisms were killed (Fig. 8 B). These data
suggest that the ability to induce megasome formation is a
unique feature of virulent Hp and support the hypothesis
that both delayed entry and megasome formation are im-
portant for Hp survival in macrophages.
Discussion
Hp has infected at least half of the world’s population. In
spite of the prevalence of this bacterium and the significant
morbidity associated with ulcer disease, our understanding
of the pathogenesis of Hp infection is in its infancy. Hp
colonizes the mucus layer of the stomach, and acidic pH
triggers bacterial invasion of the epithelium (40–43). Both
secreted bacterial factors and invasion are cytotoxic (41,
44–48), and cell death allows Hp to colonize exposed base-
ment membranes and facilitates contact with macrophages
(49–53). Although multiple studies have shown that Hp is
not readily killed by professional phagocytes, the mecha-
nism of bacterial survival has remained obscure. We now
show that phagocytosis and intracellular trafficking of un-
opsonized Hp by macrophages is characterized by two un-
usual features. First, Hp phagocytosis is delayed for several
minutes relative to other particles tested in this paper and
previous work (24, 25). Second, ingestion is followed by
homotypic phagosome fusion. The resulting phagosomes
are stable, contain multiple viable bacilli, and are named
megasomes to indicate their large size. We found that phago-
some–phagosome fusion required host cell MTs and was
restricted to metabolically active type I strains of Hp. By
contrast, type II strains of Hp, which are associated with
asymptomatic infection rather than invasive ulcer disease, were
ingested without a lag, did not induce megasome formation,
and did not persist inside macrophages. Collectively, our data
indicate that phagosome–phagosome fusion is required for
Hp survival in macrophages and as such suggest that mega-
some formation is an important aspect of Hp virulence.
Phagocytosis is driven by receptor–ligand interactions
that induce localized actin polymerization (54). Using EM,
we demonstrated that Hp was internalized into conventional
phagosomes. Importantly, however, our synchronized phago-
cytosis assay revealed that localized actin polymerization
and Hp internalization were delayed until several minutes
after bacterial attachment. To our knowledge, delayed phago-
cytosis has not previously been described for other micro-
organisms, and we have shown that phagocytosis via mannose
receptors (24), Fc receptors, or complement receptors in acti-
vated cells (25) is rapid and occurs with kinetics similar to
those shown here after Ye engagement of b1 integrin re-
ceptors. Although Chmiela et al. (55) demonstrated that sialic
acid–dependent and –independent adhesins support Hp
binding to macrophages, the receptor that mediates phago-
cytosis of these organisms has not been defined. In addition,
the mechanism by which Hp alters its ingestion is unknown.
Nonetheless, it is tempting to speculate that type I Hp may
actively impede one or more of the signaling pathways ac-
tivated during phagocytosis.
Three lines of evidence support our hypothesis that Hp
actively modulates its ingestion by macrophages. First, dead
Hp were ingested without a lag. Second, pretreatment of
organisms with chloramphenicol shortened the lag between
binding and phagocytosis such that maximum ingestion oc-
curred after 1–3 rather than 5–7 min. Third, ingestion of
Tx30a resembled that of chloramphenicol-treated 11637.
Inhibition of bacterial protein synthesis may deplete short-
lived proteins from the outer membranes of type I organ-
isms, and some or all of these proteins may be lacking in
type II strains. These data are consistent with a model in
which type I and II Hp engage different phagocytic recep-
tors. Indeed, this may also be the case for neutrophils, as
Figure 8. Tx30a does not induce megasome formation and is effi-
ciently killed. Peritoneal macrophages were infected with Hp 11637 or
Tx30a as described above. (A) After 0.5 or 2 h of phagocytosis at 378C,
fixed and permeabilized cells were stained with pAb to Hp and secondary
Abs conjugated to TRITC. Megasome formation was scored using im-
munofluorescence and phase contrast microscopy. The graph indicates
the number of megasomes as a percentage of total Hp phagosomes. Data
shown are the average 6 SD of three independent experiments con-
ducted in triplicate. (B) Phagocytic killing of Tx30a and 11637 was deter-
mined as described for Fig. 1. Initial average phagocytic indices were 735 6
20 and 670 6 26 for 11637 and Tx30a, respectively. 20 h after initiation
of phagocytosis, 99.5 6 0.4% of ingested Tx30a were killed. Data shown
are the average 6 SD of four independent experiments. Similar data were
obtained using J774 cells (data not shown).124 Phagocytosis of Helicobacter pylori
type II organisms bind poorly to these cells, whereas type I
strains are efficiently ingested (Allen, L., unpublished ob-
servation). In vivo, Hp persists at a site of inflammation,
and in this milieu Hp-phagocyte interactions may be mod-
ulated by serum opsonins. Therefore, we are currently ex-
ploring whether complement proteins or IgG alter the rate
of phagocytosis of Hp and subsequent megasome formation.
The most striking finding of this study is that phago-
somes containing single Hp underwent homotypic fusion.
Under normal circumstances, the interaction of phago-
somes with one another and with other organelles is tightly
regulated, and it is well documented that phagosomes con-
taining inert particles do not undergo homotypic fusion (19).
Therefore, the ability of Hp to induce rapid and extensive
phagosome–phagosome fusion is significant. In this regard,
Hp may most closely resemble Chlamydia trachomatis. Phago-
somes containing C. trachomatis elementary bodies fuse with
each other to generate an inclusion (56, 57), and formation
of both megasomes and inclusions requires bacterial protein
synthesis (reference 56 and this study). Nevertheless, for-
mation of these two types of organelles can be distin-
guished by the fact that megasomes are present within 30
min of Hp uptake, whereas generation of inclusions occurs
after several hours (56).
Three lines of evidence suggest that megasome forma-
tion plays a key role in Hp persistence in macrophages. First,
dead organisms were not found in megasomes. Second,
treatments that inhibited megasome formation (nocodazole,
chloramphenicol) also promoted phagocytic killing. Third,
Tx30a was unable to induce megasome formation and did
not survive in macrophages. Although megasomes have not
been characterized at the molecular level, virulence factors
that favor Hp survival in the gastric lumen might also allow
bacteria to persistence in an acidic endosomal compartment
in macrophages. Moreover, our observation that phagosome–
phagosome fusion is induced by type I but not type II or-
ganisms suggests a role for VacA and/or the cag PAI in this
process.
VacA is a “vacuolating cytotoxin” secreted by all type I
strains of Hp. VacA is activated by exposure to acidic pH
and, in epithelial cells, induces the formation of dilated acidic
vacuoles that are derived from late endosomal membranes
(58–60). These vacuoles accumulate rab 7 and lamp-1 yet
exclude mannose-6-phosphate receptors and lysosomal hy-
drolases such as cathepsin D. Although the vacA gene is
present in type II Hp, the gene sequence differs from type I
strains and the protein synthesized appears to be inactive
(6). Both vacuolation and megasome formation require in-
tact MTs (reference 60 and this study), and we found that
24 h megasomes are acidic, as judged by their accumulation
of acridine orange (reference 61 and Allen, L., unpublished
data). Thus, it is tempting to speculate that VacA may be
secreted and activated inside phagosomes and thereby pro-
mote megasome formation. We are currently investigating
whether purified VacA can induce fusion of phagosomes
containing latex beads and whether other types of phago-
somes merge with the megasome compartment in infected
macrophages. Importantly, any role of VacA in phagosome–
phagosome fusion does not exclude a role for other Hp
proteins. The cag PAI encodes a type IV secretion system (62),
and a similar secretion system is required for modification
of the L. pneumophilia phagosome in macrophages (62).
Factors secreted by the Hp type IV organelle are uncharac-
terized. Nevertheless, bacterial attachment and secretion are
required to induce IL-8 secretion from epithelial cells (62),
and this system may also play a role in delaying phagocyto-
sis of Hp or in megasome formation.
A growing body of evidence indicates that some species
of “extracellular” bacteria can infect host cells and survive
for prolonged periods in intracellular locales. With regard
to phagocytes, we show here that type I Hp survives for 24 h
in human and murine macrophages. Similarly, group B
streptococci remain viable inside macrophages for 24–48 h
(63), and Campylobacter jejuni survives inside macrophages for
6–7 d (64). It has been suggested that intracellular organ-
isms are hidden from the immune response and therefore
reside in protected niches (16, 64). However, the vacuoles
occupied by these organisms are at best only partially char-
acterized (63, 64). In all cases examined thus far, the ability
of bacteria to invade host cells appears to be restricted to
certain strains of organisms (such as clinical isolates) and is
further modulated by bacterial growth conditions (in vitro)
or local signaling events (in vivo) (63–66). For example, we
found that Hp grown at pH 6 induces more megasomes
than do bacteria grown at neutral pH (Allen, L., manuscript
in preparation). Significantly, for Hp, C. jejuni, and group
B streptococci, invasion and persistence in macrophages
occurs in the apparent absence of bacterial replication (ref-
erences 63 and 64 and this study). In fact, it may be that the
ability to replicate inside cells, rather than the ability to in-
vade and survive, is the feature that distinguishes some “in-
tracellular” and “extracellular” pathogens. Nevertheless, Hp
does not survive indefinitely inside cells, and lysis of infected
macrophages has been observed at later times (Allen, L.,
unpublished observation).
We have shown that Tx30a is efficiently ingested and
killed by macrophages in vitro. Nevertheless, infections with
type II organisms are not cleared by the host (1, 67). This
may be explained in part by the fact that type II Hp appear
to have only limited contact with phagocytes in vivo.
Tx30a and related strains lack the cag PAI and synthesize a
nontoxic form of VacA. Consequently, these organisms in-
duce only modest amounts of inflammation, and phagocyte
recruitment to the stomach is vastly reduced (1, 4, 68). Be-
cause the available data suggest that Hp–phagocyte contact
often occurs at sites of tissue damage (10–12, 17), the low
toxicity of type II Hp may allow these bacteria to persist in
the mucus layer and thereby avoid contact with macrophages.
Taken together, the results of this study demonstrate that
type I Hp are ingested by an unusual mechanism that in-
volves delayed entry followed by phagosome–phagosome
fusion. To our knowledge, this mechanism is unique to Hp.
Moreover, our results demonstrate for the first time that
“extracellular” bacteria can alter the intraphagosomal envi-
ronment in macrophages. Antibiotic resistance of Hp and
treatment failure is a rapidly growing problem (22, 69, 70).125 Allen et al.
A clear understanding of how all types of Hp avoid elimi-
nation by the host immune response is an essential first step
in the development of novel treatments for ulcer disease.
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